The target landscape of clinical kinase drugs

Susan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm, +43

Science

Tumor BiologyProteomicsdb DatabaseDrug TargetOncologyTarget Landscape +12

A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma

Maria Teresa Landi, Nilanjan Chatterjee, Kai Yu, +59

The American Journal of Human Genetics

Genome-wide Association StudyCancer RiskMedicineGeneticsChromosome 5P15 +9

Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer

Yufei Wang, James McKay, Zhaoming Wang, +77

Nature Genetics

Cancer RiskRare VariantsMedicinePathologyCancer Genomics +6

Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells

Junichi Soh, Naoki Okumura, William W. Lockwood, +16

PLoS ONE

Identification of miR‐374a as a prognostic marker for survival in patients with early‐stage nonsmall cell lung cancer

Urmo Võsa, Tõnu Vooder, Raivo Kolde, +7

Genes Chromosomes and Cancer

The role of COX-2 and Nrf2/ARE in anti-inflammation and antioxidative stress: Aging and anti-aging

Cheng Luo, Egon Urgard, Tõnu Vooder, +1

Medical Hypotheses

InflammationAntioxidative StressAgingLongevityMedicine +8

Gene Expression Profiles of Non-Small Cell Lung Cancer: Survival Prediction and New Biomarkers

Kristjan Välk, Tõnu Vooder, Raivo Kolde, +4

Oncology

Methylation Markers of Early-Stage Non-Small Cell Lung Cancer

Kaie Lokk, Tõnu Vooder, Raivo Kolde, +10

PLoS ONE

Lung cancer and DNA repair genes: multilevel association analysis from the International Lung Cancer Consortium

Rémi Kazma, Marie‐Claude Babron, Valérie Gaborieau, +15

Carcinogenesis

Mutation analysis and copy number alterations of <em>KIF23</em> in non-small-cell lung cancer exhibiting <em>KIF23</em> over-expression

Ann-Louise Vikberg, Tõnu Vooder, Kaie Lokk, +2

OncoTargets and Therapy